S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data
OncLive® On Air
00:00
Tarlatimab: DLL3-Directed T-Cell Engager
John V. Heymach explains tarlatimab's DLL3/CD3 engagement for small cell tumors and the need to recruit T cells.
Play episode from 20:42
Transcript
